Navigation Links
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
Date:9/27/2010

NEW YORK, Sept. 27 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today provided an update to its development pipeline, which includes 118 programs from Phase 1 through registration.  The updated pipeline continues to reflect Pfizer's ongoing investment in high-priority disease areas with considerable unmet medical need.  

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO)

"We continue to be confident in the progression of our late-stage pipeline and have advanced three compounds into registration since our last portfolio update," said Ian Read, president of Pfizer's Worldwide Biopharmaceutical Businesses.  "We have a strong pipeline with programs in development across important therapeutic areas including oncology, neuroscience and inflammation.  We remain committed to growing our biologics and vaccines development programs."

"Building on the rapid integration of Pfizer and Wyeth, the new Pfizer brings a wealth of scientific approaches and technologies to our key investment areas, and we are developing novel product candidates across all phases of development," said Mikael Dolsten, MD, PhD, president of Pfizer's Worldwide Research and Development.  "We are leveraging the best product assets of our legacy organizations and driving important steps forward in strategy and method to deliver a portfolio of next generation medicines and vaccines."

Pfizer now has 118 programs in Phase 1 through registration, compared to 133 programs at its last pipeline update in January, 2010.  This reflects 25 programs that are new or have advanced along the pipeline and 31 programs that have been discontinued since the last update.  The current pipeline includes 26 programs in Phase 3 and nine programs in registration, as well as 27 biologics and four vaccines across
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tianyin Corporate Presentation Updated
2. Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
3. RF Technologies(R) Installs Updated Version of its Safe Place(R) Solution for Infant Security at Sutter Tracy Community Hospital
4. Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia
5. Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
6. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
7. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
8. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
9. Newly Updated Pharmacy State Law Compendium Available
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... SAN DIEGO , March 27, 2015 /PRNewswire/ ... informatics company, today announced new data showing that, ... Mantis TM technology provided highly equivalent interpretations ... cause disease, and did so in a fraction ... pave the way for more comprehensive genetic analysis ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
Breaking Medicine Technology:New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... Md., Dec. 13, 2011 Vanda Pharmaceuticals Inc. (Vanda) ... on the development and commercialization of products for central ... with Megapharm Ltd., one of Israel,s leading private biotech, ... of Fanapt™  in Israel. "We are excited ...
... VIEW, Calif., Dec. 13, 2011 Alexza Pharmaceuticals, Inc. ... Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food ... (Staccato® loxapine) be approved for use as a single ... recommended Risk Evaluation and Mitigation Strategy (REMS), for the ...
Cached Medicine Technology:Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 4FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 2FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 3FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 4FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ 5
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes of ... time, key information for understanding and treating this intractable ... story on the Surviving Mesothelioma website. , ... British Columbia Cancer Agency, and PhenoPath lab in Seattle, ... and mutations that can lead to peritoneal mesothelioma ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
(Date:3/28/2015)... Purity Products®, a leading direct ... release of their revolutionary new weight loss product, ... double-blind, placebo-controlled clinical studies to be effective in ... MuffinStop™ is a combination of two traditionally used ... together to create one of the most innovative ...
(Date:3/27/2015)... March 27, 2015 Wellness for Cancer–the ... business criteria for the spa and wellness industry–has certified ... who have experienced or are living with cancer. ... Wellness 365® Network, will be identified with a special ... a provider of safe, therapeutic services for cancer patients. ...
(Date:3/27/2015)... First Choice Emergency Room opened its new Summerwood ... W Lake Houston Pkwy, Houston, Texas and is open 24-7. ... to delivering the highest quality emergency medical care to my ... Choice Emergency Room Summerwood. , To celebrate the ... Creek High School at First Choice Emergency Room’s ribbon cutting ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... Kate Weber, registered dietician, certified personal trainer, marathoner, and wellness enthusiast ... to live a better, longer, healthier and younger ... ... Dec. 17 be, better nutrition for active,lifestyles available exclusively at ...
... BC, Dec. 17 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals,Corporation (NASDAQ: ... Aspreva,s,shareholders and optionholders have approved the proposed acquisition ... wholly-owned Canadian,subsidiary, at a price of US$26.00 per ... held this morning, the transaction was approved,by over ...
... U.S. hospitals , , MONDAY, Dec. 17 (HealthDay News) -- ... pain and anxiety that often follows major surgery, new ... response was equivalent to a [dose] of morphine, which ... B. Hinshaw, professor of surgery and a member of ...
... with their teeth than professionals might think, survey finds , , ... much happier with the condition of their teeth and smiles ... view eyes and teeth as the most important aspects of ... ease with the appearance of their teeth, the study found. ...
... Aim to Facilitate the Training of Interventional Cardiologists ... Treat Growing Population of Cardiovascular Patients, ... launched today by the,Society for Cardiovascular Angiography and ... fund approved training positions,thereby expanding the number of ...
... CSG/SportsCoatings,today announced a major deal that ... FabricAide(TM), to 25 high schools in,Virginia,s Fairfax ... District is the model for how schools ... towards minimizing prevalent,bacterial issues like staph and ...
Cached Medicine News:Health News:be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 3Health News:Aspreva obtains shareholder approval for acquisition by Galenica 4Health News:Massage Eases Pain, Anxiety After Surgery 2Health News:Dentists Take Dimmer View of Patients' Smiles 2Health News:Dentists Take Dimmer View of Patients' Smiles 3Health News:Dentists Take Dimmer View of Patients' Smiles 4Health News:SCAI Announces New Program to Support Interventional Cardiology Training Fellowships 2Health News:SCAI Announces New Program to Support Interventional Cardiology Training Fellowships 3Health News:Virginia School District Gets Proactive Against MRSA 2
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: